Center for Health Outcomes Research, United BioSource Corporation, London, United Kingdom.
Am J Rhinol Allergy. 2010 Jan-Feb;24(1):34-8. doi: 10.2500/ajra.2010.24.3394.
Patients report that nasal congestion is the most bothersome symptom of allergic rhinitis (AR). Recently, a short, patient-reported congestion screener questionnaire, the Congestion Quantifier Seven-Item Test (CQ7), was developed to identify a level of congestion that may warrant patients seeking evaluation and possible treatment. We explored further item reduction of the CQ7 and examined the psychometric properties of this reduced set of items in a 15-day study of patients with confirmed AR or self-identified and clinician-confirmed congestion.
The CQ7 was subjected to item reduction methods and the psychometric properties of the reduced set of items were assessed.
Two items were dropped-sinus pressure/pain and impact on work/school-because of lower item-rest correlations. The resulting Congestion Quantifier Five-Item screener (CQ5) performed comparably with the CQ7. Internal consistency reliability of both instruments were identical (alpha = 0.93); test-retest reliability from baseline to day 15 was similar (CQ7, alpha = 0.85; CQ5, alpha = 0.79). Both instruments were comparable in discriminating patients and controls (CQ7, area under the curve [AUC] = 0.97; CQ5, AUC = 0.96). A CQ5 score of 6 provided optimum balance of sensitivity (89.4%), specificity (88.6%), and correct classification (89%) for detecting congestion.
The CQ5, a patient-reported outcome screener, is slightly shorter but equally reliable, valid, and responsive as the CQ7 for evaluating differences in levels of severity of nasal congestion. It may have wider applicability than the CQ7 because of exclusion of the work/school impact item.
患者报告称鼻塞是变应性鼻炎(AR)最恼人的症状。最近,开发了一种简短的、患者报告的鼻塞筛查问卷,即鼻塞量化七项测试(CQ7),以确定可能需要患者寻求评估和可能治疗的鼻塞程度。我们进一步探讨了 CQ7 的项目删减,并在一项为期 15 天的、患有确诊 AR 或自我识别和临床医生确诊的鼻塞患者的研究中,考察了这组简化项目的心理测量学特性。
对 CQ7 进行项目删减方法,评估简化后项目集的心理测量学特性。
由于项目间相关性较低,删除了两个项目——鼻窦压力/疼痛和对工作/学校的影响。由此产生的鼻塞量化五项目筛查器(CQ5)与 CQ7 性能相当。两种仪器的内部一致性信度相同(α=0.93);从基线到第 15 天的测试-重测信度相似(CQ7,α=0.85;CQ5,α=0.79)。两种仪器在区分患者和对照组方面具有可比性(CQ7,曲线下面积 [AUC] = 0.97;CQ5,AUC = 0.96)。CQ5 得分 6 为检测鼻塞提供了最佳的敏感性(89.4%)、特异性(88.6%)和正确分类(89%)的平衡。
CQ5 是一种患者报告的结局筛查器,与 CQ7 相比,它稍短,但在评估鼻塞严重程度的差异方面具有相同的可靠性、有效性和反应性。由于排除了对工作/学校的影响项目,它可能比 CQ7 具有更广泛的适用性。